These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7985944)

  • 21. Is lipoprotein (a)-apheresis useful?
    Bambauer R
    Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol.
    Opole IO; Belmont JM; Kumar A; Moriarty PM
    Am J Cardiol; 2007 Nov; 100(9):1416-8. PubMed ID: 17950800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [LDL-apheresis: current status].
    Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S
    Clin Ter; 2001; 152(1):65-9. PubMed ID: 11382172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspectives for apheresis in hypercholesterolaemia.
    Jacobs P; Marais D
    Transfus Sci; 1993 Jul; 14(3):219-21. PubMed ID: 10146334
    [No Abstract]   [Full Text] [Related]  

  • 25. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
    Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl WH; Derfler K
    J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary plaque regression: role of low density lipoprotein-apheresis.
    Barter PJ
    J Am Coll Cardiol; 2002 Jul; 40(2):228-30. PubMed ID: 12106924
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
    Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
    Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relation of serum lipids disorders and ischemic heart disease in diabetics].
    Muto E
    Hokkaido Igaku Zasshi; 1989 Jul; 64(4):406-10. PubMed ID: 2583664
    [No Abstract]   [Full Text] [Related]  

  • 29. Apheresis in coronary heart disease with elevated Lp (a): a review of Lp (a) as a risk factor and its management.
    Keller C
    Ther Apher Dial; 2007 Feb; 11(1):2-8. PubMed ID: 17309568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
    Schuff-Werner P
    Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
    Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
    Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of myocardial perfusion after low-density lipoprotein apheresis treatment.
    Jovin IS; Taborski U; Müller KD; Müller-Berghaus G
    Eur Heart J; 1997 Mar; 18(3):531-2. PubMed ID: 9076399
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma exchange in type II hypercholesterolemia.
    Kamanabroo D; Ulrich K; Gröbe H; Assmann G
    Prog Clin Biol Res; 1988; 255():347-56. PubMed ID: 3340644
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment by LDL-apheresis during pregnancy].
    Schlienger JL; Brignon P; Grunenberger F
    Presse Med; 2003 Apr; 32(13 Pt 1):603. PubMed ID: 12718320
    [No Abstract]   [Full Text] [Related]  

  • 35. [Low density lipoprotein apheresis therapy during pregnancy].
    Schlienger JL; Brignon P; Grunenberger F
    Presse Med; 2003 Jun; 32(22):1031. PubMed ID: 12894777
    [No Abstract]   [Full Text] [Related]  

  • 36. [Plasma exchange and related forms of therapy in severe familial hypercholesterolemia].
    Keller C
    Verh Dtsch Ges Inn Med; 1986; 92():419-24. PubMed ID: 3811543
    [No Abstract]   [Full Text] [Related]  

  • 37. The lower the better: target values after LDL-Apheresis and semi-selective LDL-elimination therapies.
    Borberg H
    Transfus Apher Sci; 2013 Apr; 48(2):127. PubMed ID: 23785717
    [No Abstract]   [Full Text] [Related]  

  • 38. [Correction of electrolyte balance during extracorporeal regulation of the blood composition in patients with ischemic heart disease].
    Pisarevskiĭ AA; Gavrilov AO; Nevskaia TR; Grachev SP; Dobashina AN
    Anesteziol Reanimatol; 1988; (6):38-40. PubMed ID: 3245619
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of hemosorption in patients with ischemic heart disease].
    Orlov VA; Khishtovani AI; Berezov VP; Dmitriev AI
    Klin Med (Mosk); 1985 Jul; 63(7):101-5. PubMed ID: 4046522
    [No Abstract]   [Full Text] [Related]  

  • 40. Europe aspires to set the record straight on familial hypercholesterolaemia.
    Watts GF; Pang J; Santos RD
    Atherosclerosis; 2015 Aug; 241(2):769-71. PubMed ID: 25934115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.